88 related articles for article (PubMed ID: 25190103)
1. Nuclear ING2 expression is reduced in osteosarcoma.
Han XR; Bai XZ; Sun Y; Yang Y
Oncol Rep; 2014 Nov; 32(5):1967-72. PubMed ID: 25190103
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients.
Pan YQ; Zhang X; Xu DP; Bao WG; Lin AF; Xu HH; Yan WH
Neoplasma; 2014; 61(4):468-75. PubMed ID: 24712846
[TBL] [Abstract][Full Text] [Related]
3. Nuclear ING2 expression is reduced in human cutaneous melanomas.
Lu F; Dai DL; Martinka M; Ho V; Li G
Br J Cancer; 2006 Jul; 95(1):80-6. PubMed ID: 16755297
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of inhibitor of growth protein 2 inhibits cell invasion and enhances chemosensitivity to 5-FU in human gastric cancer cells.
Zhong J; Yang L; Liu N; Zheng J; Lin CY
Dig Dis Sci; 2013 Nov; 58(11):3189-97. PubMed ID: 23864195
[TBL] [Abstract][Full Text] [Related]
5. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
[TBL] [Abstract][Full Text] [Related]
6. ING1 and ING2: multifaceted tumor suppressor genes.
Guérillon C; Larrieu D; Pedeux R
Cell Mol Life Sci; 2013 Oct; 70(20):3753-72. PubMed ID: 23412501
[TBL] [Abstract][Full Text] [Related]
7. Expression profiles of inhibitor of growth protein 2 in normal and cancer tissues: An immunohistochemical screening analysis.
Zhao S; Yang XF; Gou WF; Lu H; Li H; Zhu ZT; Sun HZ; Zheng HC
Mol Med Rep; 2016 Feb; 13(2):1881-7. PubMed ID: 26717876
[TBL] [Abstract][Full Text] [Related]
8. Nuclear phosphatidylinositol-5-phosphate regulates ING2 stability at discrete chromatin targets in response to DNA damage.
Bua DJ; Martin GM; Binda O; Gozani O
Sci Rep; 2013; 3():2137. PubMed ID: 23823870
[TBL] [Abstract][Full Text] [Related]
9. ING2, a tumor associated gene, enhances PAI‑1 and HSPA1A expression with HDAC1 and mSin3A through the PHD domain and C‑terminal.
Ohkouchi C; Kumamoto K; Saito M; Ishigame T; Suzuki SI; Takenoshita S; Harris CC
Mol Med Rep; 2017 Nov; 16(5):7367-7374. PubMed ID: 28944862
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma.
Zhang HK; Pan K; Wang H; Weng DS; Song HF; Zhou J; Huang W; Li JJ; Chen MS; Xia JC
Cancer Lett; 2008 Mar; 261(2):183-92. PubMed ID: 18160212
[TBL] [Abstract][Full Text] [Related]
11. ING2 controls the G1 to S-phase transition by regulating p21 expression.
Larrieu D; Ythier D; Brambilla C; Pedeux R
Cell Cycle; 2010 Oct; 9(19):3984-90. PubMed ID: 20890119
[TBL] [Abstract][Full Text] [Related]
12. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
13. Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma.
Ythier D; Brambilla E; Binet R; Nissou D; Vesin A; de Fraipont F; Moro-Sibilot D; Lantuejoul S; Brambilla C; Gazzeri S; Pedeux R
Lung Cancer; 2010 Aug; 69(2):180-6. PubMed ID: 19962781
[TBL] [Abstract][Full Text] [Related]
14. ING2 in cell cycle regulation.
Li G; Piche B
Cell Cycle; 2010 Oct; 9(19):3846. PubMed ID: 20948283
[No Abstract] [Full Text] [Related]
15. Leucine zipper-like domain is required for tumor suppressor ING2-mediated nucleotide excision repair and apoptosis.
Wang Y; Wang J; Li G
FEBS Lett; 2006 Jul; 580(16):3787-93. PubMed ID: 16782091
[TBL] [Abstract][Full Text] [Related]
16. ING2 controls the progression of DNA replication forks to maintain genome stability.
Larrieu D; Ythier D; Binet R; Brambilla C; Brambilla E; Sengupta S; Pedeux R
EMBO Rep; 2009 Oct; 10(10):1168-74. PubMed ID: 19730436
[TBL] [Abstract][Full Text] [Related]
17. Sumoylation of ING2 regulates the transcription mediated by Sin3A.
Ythier D; Larrieu D; Binet R; Binda O; Brambilla C; Gazzeri S; Pedeux R
Oncogene; 2010 Nov; 29(44):5946-56. PubMed ID: 20676127
[TBL] [Abstract][Full Text] [Related]
18. The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor.
Gozani O; Karuman P; Jones DR; Ivanov D; Cha J; Lugovskoy AA; Baird CL; Zhu H; Field SJ; Lessnick SL; Villasenor J; Mehrotra B; Chen J; Rao VR; Brugge JS; Ferguson CG; Payrastre B; Myszka DG; Cantley LC; Wagner G; Divecha N; Prestwich GD; Yuan J
Cell; 2003 Jul; 114(1):99-111. PubMed ID: 12859901
[TBL] [Abstract][Full Text] [Related]
19. ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression.
Kumamoto K; Fujita K; Kurotani R; Saito M; Unoki M; Hagiwara N; Shiga H; Bowman ED; Yanaihara N; Okamura S; Nagashima M; Miyamoto K; Takenoshita S; Yokota J; Harris CC
Int J Cancer; 2009 Sep; 125(6):1306-15. PubMed ID: 19437536
[TBL] [Abstract][Full Text] [Related]
20. ING2 as a novel mediator of transforming growth factor-beta-dependent responses in epithelial cells.
Sarker KP; Kataoka H; Chan A; Netherton SJ; Pot I; Huynh MA; Feng X; Bonni A; Riabowol K; Bonni S
J Biol Chem; 2008 May; 283(19):13269-79. PubMed ID: 18334480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
